GlaxoSmithKline Said to Settle U.S. Lawsuit for $750 Million

GlaxoSmithKline Plc settled a U.S. government lawsuit under the False Claims Act for $750 million, according to a person familiar with the matter.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE